Mr William Bolton, MD | |
820 S 14th St, Thermopolis, WY 82443-3102 | |
(307) 864-5420 | |
Not Available |
Full Name | Mr William Bolton |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 820 S 14th St, Thermopolis, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255451324 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 2339A (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr William Bolton, MD 820 S 14th St, Thermopolis, WY 82443-3102 Ph: (307) 864-5420 | Mr William Bolton, MD 820 S 14th St, Thermopolis, WY 82443-3102 Ph: (307) 864-5420 |
News Archive
Even though the incidence of atrial fibrillation is higher in men than women, a review of past studies and medical literature completed by cardiac experts at Rush University Medical Center shows that women are more likely than men to experience symptomatic attacks, a higher frequency of recurrences, and significantly higher heart rates during atrial fibrillation, which increases the risk of stroke.
The U.S. Department of Health and Human Services (HHS) today announced contract awards for up to 120,000 treatment courses of intravenous (IV) antiviral drugs to help treat hospitalized 2009 H1N1 influenza patients.
Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for treating dental erosion. Dental erosion is a common, growing condition that impacts all ages and for which there is currently no effective treatment. The condition is estimated to affect 15-50% of the population and it is sometimes referred to as the "new caries".
​Researchers have discovered the genetic processes that cause specific types of bowel cancer. Using this knowledge, they identified cancer drugs that target these genes. Their findings offer the opportunity to develop personalised treatment based on a person's genetic profile.
nited BioSource Corporation (UBC) today announced the opening of its newest global office in Tokyo, Japan. The UBC office will be led by Kumpei Kobayashi, PharmD, a biopharmaceutical industry veteran with over 20 years of product development experience throughout the Asia-Pacific region.
› Verified 8 days ago